Rather than relying on technological novelty, emerging biotechs must leverage strategic content and marketing intelligence to ...
NewcelX Ltd. (Nasdaq: NCEL),– NewcelX Ltd. (Nasdaq: NCEL), a clinical-stage regenerative medicine company developing stem-cell-derived therapies, today announced the release of an updated corporate ...
Educational session at the Membrane Technology Forum examines how food and beverage manufacturers are evaluating membrane ...
AI success depends on leadership, culture and talent. Here are three actions executives should take now to build a ...
Educational session explores how evolving consumer trends, product innovation cycles and shifting distribution models are ...
This is read by an automated voice. Please report any issues or inconsistencies here. The data on traditional PowerPoint decks is in, and it’s time for a new coat of paint Recent data reveals that ...
Indeed, many of the issues affecting the indie space in 2026 are double-edged. While many bemoaned the flood of content on ...
Good afternoon, and welcome to the presentation of Akastor's first quarter results. My name is Oyvind Paaske, CFO, and I'm joined today by our CEO, Karl Erik Kjelstad.
Part 1 of this series focused on diligence and opinions. Patent prosecution is undergoing the same transition: AI has ...
WebFX shares more than 60 AI prompt examples for marketers, emphasizing the importance of specific prompts for effective AI ...
Biomerica, Inc. (Nasdaq: BMRA), a global biomedical technology company focused on innovative diagnostic-guided therapies, today announced that an abstract evaluating the real-world clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results